TGFB1 and ovarian neoplasm: Taken together, these findings demonstrate that miR-675 expression suppresses primary ovarian tumor growth and metastasis in part by targeting the TGFβ1, inhibiting EMT through attenuating the TGFβ pathway (Fig. 8), suggesting the potential of miR-675 as a therapeutic strategy for OC patients.